Analyzing Lucira Health (LHDXQ) and Its Competitors
Analyzing Lucira Health (LHDXQ) and Its Competitors
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its peers? We will compare Lucira Health to similar businesses based on the strength of its dividends, analyst recommendations, institutional ownership, valuation, risk, profitability and earnings.
Lucira Health（纳斯达克股票代码：LHDXQ — 获取评级）是 “诊断物质” 行业的41家上市公司之一，但它与同行相比有何不同？我们将根据Lucira Health的股息实力、分析师建议、机构所有权、估值、风险、盈利能力和收益将Lucira Health与类似业务进行比较。
Analyst Recommendations
分析师建议
This is a summary of recent ratings for Lucira Health and its peers, as provided by MarketBeat.
这是MarketBeat提供的Lucira Health及其同行最近评级的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 365 | 629 | 1235 | 19 | 2.40 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不适用 |
| 露西拉健康竞争对手 | 365 | 629 | 1235 | 19 | 2.40 |
As a group, "Diagnostic substances" companies have a potential upside of 33.93%. Given Lucira Health's peers higher possible upside, analysts plainly believe Lucira Health has less favorable growth aspects than its peers.
作为一个整体，“诊断物质” 公司的潜在上涨空间为33.93％。鉴于Lucira Health的同行可能有更高的上行空间，分析师显然认为Lucira Health的增长方面不如同行。
Earnings & Valuation
收益与估值
This table compares Lucira Health and its peers gross revenue, earnings per share and valuation.
该表比较了Lucira Health及其同行的总收入、每股收益和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.03 |
| Lucira Health Competitors | $480.44 million | $10.72 million | -52.66 |
| 总收入 | 净收入 | 市盈率 | |
| 露西拉健康 | 9306 万美元 | -6,483 万美元 | -0.03 |
| 露西拉健康竞争对手 | 4.8044 亿美元 | 1,072 万美元 | -52.66 |
Lucira Health's peers have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Lucira Health的同行比Lucira Health的收入和收益更高。Lucira Health的市盈率高于同行，这表明它目前比该行业的其他公司更昂贵。
Insider and Institutional Ownership
内部所有权和机构所有权
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 46.6% of shares of all "Diagnostic substances" companies are held by institutional investors. 30.4% of Lucira Health shares are held by company insiders. Comparatively, 14.1% of shares of all "Diagnostic substances" companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Lucira Health的57.0％股票由机构投资者持有。相比之下，所有 “诊断物质” 公司的46.6％的股份由机构投资者持有。Lucira Health的股份中有30.4％由公司内部人士持有。相比之下，所有 “诊断物质” 公司的14.1％的股份由公司内部人士持有。强大的机构所有权表明对冲基金、捐赠基金和大型基金经理认为股票有望实现长期增长。
Profitability
盈利能力
This table compares Lucira Health and its peers' net margins, return on equity and return on assets.
该表比较了Lucira Health及其同行的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -802.63% | -114.55% | -27.76% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| 露西拉健康竞争对手 | -802.63% | -114.55% | -27.76% |
Risk and Volatility
风险和波动性
Lucira Health has a beta of 3.36, indicating that its share price is 236% more volatile than the S&P 500. Comparatively, Lucira Health's peers have a beta of 1.37, indicating that their average share price is 37% more volatile than the S&P 500.
Lucira Health的beta值为3.36，这表明其股价的波动性比标准普尔500指数高236％。相比之下，Lucira Health的同行beta值为1.37，这表明他们的平均股价的波动性比标准普尔500指数高37％。
Summary
摘要
Lucira Health beats its peers on 7 of the 10 factors compared.
在比较的10个因素中，Lucira Health在7个方面击败了同行。
About Lucira Health
关于 Lucira Health
(Get Rating)
（获取评分）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家医疗技术公司。它专注于变革性和传染病检测试剂盒的开发和商业化。Lucira Health Inc. 总部位于加利福尼亚州的埃默里维尔。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Lucira Health及相关公司的最新新闻和分析师评级的简明每日摘要。